Mexico · Delayed Price · Currency is MXN Medpace Holdings Company Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas.
It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services.
In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials.
Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
| Country | United States |
| Founded | 1992 |
| Industry | Commercial Physical and Biological Research |
| Employees | 5,900 |
| CEO | August Troendle |
Contact Details
Address: 5375 Medpace Way Cincinnati, Delaware 45227 United States | |
| Phone | (513) 579-9911 |
| Website | medpace.com |
Stock Details
| Ticker Symbol | MEDP |
| Exchange | Mexican Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| August Troendle | Chief Executive Officer |
| Kevin Brady | Chief Financial Officer |
| Susan Burwig | Chief Operating Officer |
| Lauren Morris | Head of Investor Relations |